retatrutide side effects effects: what the trials show and how to manage them Retatrutide side effects: GI, heart,

And the risks of untreated obesitydiabetes, heart disease, cancerare far more dangerous

New research published in JACC , the flagship journal of the American College of Cardiology, and presented just last month at the 2024 American Heart Association Scientific Sessions revealed that GLP-1 drugs, including semaglutide, offer cardiovascular benefits beyond weight loss

Adequate protein intake, hydration, and nutrient-dense foods support both milk production and weight loss, though weight loss rates may be slower than with medication

The launch of Lilly's oral GLP-1 pill called orforglipron is expected to expand the addressable market